UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000044108
Receipt number R000050258
Scientific Title Creating an AI model for hoarseness classification using speech analysis in the perioperative period
Date of disclosure of the study information 2021/05/24
Last modified on 2021/12/02 13:09:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Creating an AI model for hoarseness classification using speech analysis in the perioperative period

Acronym

Creating an AI model for hoarseness classification using speech analysis in the perioperative period

Scientific Title

Creating an AI model for hoarseness classification using speech analysis in the perioperative period

Scientific Title:Acronym

Creating an AI model for hoarseness classification using speech analysis in the perioperative period

Region

Japan


Condition

Condition

Thyroid Surgery
Esophageal Cancer Surgery
Dissociative Aortic Aneurysm Surgery

Classification by specialty

Surgery in general Vascular surgery Oto-rhino-laryngology
Anesthesiology Intensive care medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

With the recent development of artificial intelligence (AI) technology, speech analysis systems and machine learning have become an integral part of our lives. We hypothesized that by using speech analysis systems and machine learning, it would be possible to predict the diagnosis of antegrade nerve palsy in the perioperative period using the patient's voice. In this study, we aim to create a hoarseness classification AI model using a speech analysis system. If we can identify antegrade nerve palsy (hoarseness) by voice analysis, we can easily predict the diagnosis of antegrade nerve palsy without causing patient distress, and reduce complications in the perioperative period.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The purpose of this study is to create an AI model for hoarseness classification using a speech analysis system.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients scheduled for esophageal cancer surgery, dissecting aortic aneurysm surgery, or thyroid surgery at Yamagata University Hospital.

Key exclusion criteria

Patients who were not able to cooperate in the study.

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Tatsuya
Middle name
Last name Hayasaka

Organization

Yamagata University Hospital

Division name

Department of Anesthesia

Zip code

9909585

Address

2-2-2, Iida-Nishi, Yamagata City

TEL

023-628-5400

Email

hayasakatatsuya1101@gmail.com


Public contact

Name of contact person

1st name Tatsuya
Middle name
Last name Hayasaka

Organization

Yamagata University Hospital

Division name

Department of Anesthesia

Zip code

9909585

Address

2-2-2, Iida-Nishi, Yamagata City

TEL

023-628-5400

Homepage URL


Email

hayasakatatsuya1101@gmail.com


Sponsor or person

Institute

Department of Anesthesiology, Yamagata University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Department of Anesthesiology, Yamagata University School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Yamagata University Medical Ministry Council

Address

2-2-2 Iida-Nishi, Yamagata City, Yamagata Prefecture

Tel

0236285015

Email

ikekenkyu@jm.kj.yamagata-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 05 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2021 Year 05 Month 24 Day

Date of IRB

2021 Year 05 Month 01 Day

Anticipated trial start date

2021 Year 05 Month 24 Day

Last follow-up date

2023 Year 05 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Patients who will undergo thyroid surgery, esophageal cancer surgery, or aortic aneurysm resection at Yamagata University Hospital between June 2021 and June 2023 will be included in the study. Before the surgery (from admission to the day before the surgery), the voice of the target patients (according to previous studies, "A-I-U-E-O", "the word 'Jack and the Beanstalk'", and a section of ATR503 sentence (about 2-3 minutes)) will be collected. After completion of the surgery, vocal fold movements will be recorded by laryngeal fiber, which is performed in normal practice (normal vocal fold movement and presence of antegrade nerve palsy will be the correct labels). After the next day of surgery, collect the voice as before the surgery. The voices of patients with a difference in voice are classified as positive, and those with no difference in voice are classified as negative. Using 80% of the total data as train data, an AI model is created based on the positive/negative data and laryngeal fiber findings. We used 20% of the total data as test data to draw ROC curve and calculate AUC.

As a secondary evaluation, we will use preoperative patient data (age, gender, height, weight, body temperature, heart rate, blood pressure, oxygenation capacity, etc.) and intraoperative findings such as surgical site to examine the correlation with recurrent nerve palsy by deep learning.


Management information

Registered date

2021 Year 05 Month 05 Day

Last modified on

2021 Year 12 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050258


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name